ascopubs.org3d
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States
LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations Among 187 patients identified (median follow-up, 22.4 ...
ascopubs.org4d
Automated Identification of Breast Cancer Relapse in Computed Tomography Reports Using Natural Language Processing
Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models We analyzed follow-up CT reports from patients diagnosed with breast cancer ...
ascopubs.org4d
Automated Identification of Breast Cancer Relapse in Computed Tomography Reports Using Natural Language Processing
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic Treatment We analyzed follow-up CT reports from patients ...
ascopubs.org5d
Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial Pancreatic ductal adenocarcinoma (PDAC) is the third ...
ascopubs.org5d
Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study
Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing Administration The concept of time toxicity of cancer treatment, defined as ...
ascopubs.org5d
Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study
Many patients with IBC in LMICs are not receiving TMT. Barriers to diagnosis and treatment were at least partially related to limited providers' comfort level and knowledge, suggesting that ...
ascopubs.org5d
Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting
Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients The three-center Mayo Clinic experience with ...
ascopubs.org5d
Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and Progress
In response to these challenges, numerous organizations, institutions, and initiatives have emerged to address the quality of cancer care on a global scale. These initiatives aim to improve patient ...
ascopubs.org5d
Prospective Observational Study on Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer in Rwanda: Acute Toxicity in Patients
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico Moderate hypofractionation (MHF) offers ...
ascopubs.org5d
Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma ...
ascopubs.org5d
Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients
Should Our Patients Go to Disney World? Weighing the Risk of Infection Versus the Benefits of Social Interactions in Our Pediatric Oncology Patients The following represents disclosure information ...